Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor in ESRD Patients on Hemodialysis
NCT01764854Phase 2Completed
- Sponsor
- Ardelyx
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenapanor in end stage renal disease (ESRD), sponsored by Ardelyx. Started Jan 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01764854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764854.